IMMUNOLOGICAL TARGETING OF PATHOLOGICAL TAU PROTEINS

    公开(公告)号:EP4218794A3

    公开(公告)日:2023-09-13

    申请号:EP23159184.3

    申请日:2010-06-10

    Abstract: The present invention relates to methods and compositions for treating, preventing, and diagnosing Alzheimer's Disease or other tauopathies in a subject by administering an immunogenic tau peptide or an antibody recognizing the immunogenic tau epitope under conditions effective to treat, prevent, or diagnose Alzheimer's Disease or other tauopathies. Also disclosed are methods of promoting clearance of aggregates from the brain of the subject and of slowing progression of tau-pathology related behavioral phenotype in a subject.

    IMMUNOLOGICAL TARGETING OF PATHOLOGICAL TAU PROTEINS

    公开(公告)号:EP4218794A2

    公开(公告)日:2023-08-02

    申请号:EP23159184.3

    申请日:2010-06-10

    Abstract: The present invention relates to methods and compositions for treating, preventing, and diagnosing Alzheimer's Disease or other tauopathies in a subject by administering an immunogenic tau peptide or an antibody recognizing the immunogenic tau epitope under conditions effective to treat, prevent, or diagnose Alzheimer's Disease or other tauopathies. Also disclosed are methods of promoting clearance of aggregates from the brain of the subject and of slowing progression of tau-pathology related behavioral phenotype in a subject.

Patent Agency Ranking